Skip to main content

Table 3 Characteristics of the femoropopliteal lesions in both PCD and POBA groups

From: Paclitaxel and mortality in patients with claudication and de novo femoropopliteal lesions: a historical cohort study

 

POBA (n = 380)

PCD (n = 320)

p-value

Mean Lesion Length (mm)

111 + −89

135 + −91

p < 0.001

Occlusion

40.2% (n = 177)

50% (n = 199)

p = 0.005

De Novo Lesion

100% (n=)

100% (n=)

N/A

Reccurent lesion

0% (n = 0)

0% (n = 0)

N/A

Prior Femoropopliteal Bypass

0% (n = 0)

0% (n = 0)

N/A

Bilateral Treatment

16.3% (n = 62)

24.3% (n = 78)

p < 0.01